Solifenacin

Generic Name: Solifenacin

Brand Names: Vesicare

Solifenacin is an antimuscarinic medication for overactive bladder, reducing urinary frequency, urgency, and incontinence.

UrologyOveractive Bladder

Drug Class

Muscarinic Receptor Antagonist (M3-selective Anticholinergic)

Pregnancy

Not formally categorized; animal studies showed adverse effects — use during pregnancy only if clearly needed

Available Forms

5 mg oral tablet, 10 mg oral tablet

What It's Used For

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

Condition	Starting Dose	Typical Maintenance Dose
Overactive bladder (OAB) with urgency, frequency, and urge incontinence	5 mg once daily	5 mg once daily; may increase to 10 mg once daily if tolerated
OAB with hepatic impairment (moderate, Child-Pugh B)	5 mg once daily	5 mg once daily (do not exceed)
OAB with severe renal impairment (CrCl <30) or strong CYP3A4 inhibitor use	5 mg once daily	5 mg once daily (do not exceed)

Side Effects

Common Side Effects:

Dry mouth (most common)
Constipation
Blurred vision
Urinary tract infection
Dyspepsia
Dry eyes
Fatigue

Serious Side Effects:

Angioedema
QT prolongation
Hallucinations (especially elderly)
Urinary retention
Glaucoma exacerbation
Severe constipation/fecal impaction

Drug Interactions

Major Drug & Food Interactions

Strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin): Significantly increases solifenacin levels; do not exceed 5 mg daily dose when co-administered.
Other anticholinergic medications (oxybutynin, tolterodine, tiotropium, diphenhydramine, tricyclic antidepressants): Additive anticholinergic effects increase risk of dry mouth, constipation, urinary retention, blurred vision, cognitive impairment, and heat stroke.
Strong CYP3A4 inducers (rifampin, phenytoin, carbamazepine): May reduce solifenacin effectiveness; consider dose adjustment or alternative therapy.
QT-prolonging drugs (amiodarone, sotalol, haloperidol, ondansetron): Solifenacin has been associated with rare QT prolongation; use caution when combining with other QT-prolonging agents.
Cholinesterase inhibitors (donepezil, rivastigmine): Pharmacologic antagonism; anticholinergics may reduce the efficacy of cholinesterase inhibitors used for dementia.

Additional Information

Solifenacin is an antimuscarinic (anticholinergic) medication used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. It offers once-daily dosing and selectivity for the M3 muscarinic receptor.

Mechanism of Action

Solifenacin works through muscarinic receptor antagonism:

M3 receptor selectivity: Greater affinity for M3 than M2 muscarinic receptors
Bladder smooth muscle relaxation: M3 receptors mediate detrusor muscle contraction
Reduces involuntary contractions: Decreases detrusor overactivity during filling phase
Increases bladder capacity: Allows greater urine storage before urgency
Long half-life: Enables once-daily dosing

Available Formulations

Solifenacin is available as film-coated tablets:

5 mg tablets
10 mg tablets

Also available in combination with mirabegron (Vibegron).

Medical Uses

FDA-Approved Indication:

Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency

Dosing Guidelines

Adults:

Starting dose: 5 mg once daily
May increase to 10 mg once daily if needed
Swallow tablets whole with liquids

Renal Impairment (CrCl <30 mL/min):

Do not exceed 5 mg daily

Hepatic Impairment:

Moderate (Child-Pugh B): Do not exceed 5 mg daily
Severe (Child-Pugh C): Not recommended

With Strong CYP3A4 Inhibitors:

Do not exceed 5 mg daily

Important Safety Information

Contraindications:

Urinary retention
Gastric retention
Uncontrolled narrow-angle glaucoma
Known hypersensitivity to solifenacin

Warnings and Precautions:

Angioedema: Discontinue immediately if occurs
Central nervous system effects: Somnolence, hallucinations reported
QT prolongation: Use with caution in patients at risk
Decreased gastric motility: Use with caution in severe constipation or GI obstruction
Controlled narrow-angle glaucoma: Use with caution
Hepatic and renal impairment: Dose adjustment required
Cognitive effects: May impair ability to drive; particularly concerning in elderly

Drug Interactions

Strong CYP3A4 Inhibitors (ketoconazole, clarithromycin, ritonavir):

Limit solifenacin to 5 mg daily

CYP3A4 Inducers (rifampin):

May reduce solifenacin efficacy; no specific recommendation

Other Anticholinergics:

Additive anticholinergic effects; use caution

Cholinesterase Inhibitors:

Antagonistic effects; avoid combination if possible

QT-Prolonging Drugs:

Use with caution; additive effects possible

Special Populations

Hepatic Impairment:
- Moderate: Max 5 mg daily
- Severe: Not recommended
Renal Impairment (CrCl <30): Max 5 mg daily
Elderly: Use with caution; higher sensitivity to anticholinergic effects
Pregnancy: Limited data; use only if benefit outweighs risk
Lactation: Unknown if excreted in milk
Pediatric: Safety not established; not recommended

Frequently Asked Questions

Solifenacin blocks muscarinic M3 receptors on the detrusor (bladder) muscle, which reduces involuntary bladder contractions. This decreases urgency, reduces the number of urinary frequency episodes, and helps control urge incontinence. Most patients notice improvement within 1–2 weeks, with full benefit by 4–8 weeks.

Dry mouth is the most common side effect, reported in about 11% of patients at 5 mg and 22% at 10 mg. Staying well hydrated, chewing sugar-free gum, and using saliva substitutes can help. If dry mouth is intolerable, your doctor may adjust the dose or switch to an alternative treatment like mirabegron, which works through a different mechanism.

Solifenacin should be used cautiously in older adults due to increased sensitivity to anticholinergic side effects, including cognitive impairment, confusion, falls, constipation, and urinary retention. The American Geriatrics Society Beers Criteria lists anticholinergics as potentially inappropriate for older adults. Discuss the risks and benefits with your doctor.

Solifenacin is an anticholinergic that blocks bladder muscle contractions. Mirabegron is a beta-3 agonist that relaxes the bladder muscle through a completely different pathway. Mirabegron avoids classic anticholinergic side effects (dry mouth, constipation, cognitive effects). Some patients who cannot tolerate solifenacin may do better with mirabegron, and the two can even be combined for refractory OAB.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

✓Am I at risk for anticholinergic side effects given my age and other medications?
✓Would mirabegron be a safer alternative for me compared to solifenacin?
✓Could my overactive bladder symptoms have a treatable underlying cause we should investigate?
✓Should I try behavioral therapies like bladder training in addition to medication?

Schedule an Appointment

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Attention Deficit Hyperactivity Disorder (ADHD)

ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and/or impulsivity, stemming from complex interactions between genetics, brain differences, and environmental factors, not poor parenting.

Learn More

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common, non-cancerous condition in aging men causing urinary symptoms due to prostate growth pressing on the urethra.

Learn More

Glaucoma

Glaucoma encompasses eye conditions damaging the optic nerve, often due to elevated eye pressure, leading to irreversible vision loss if untreated; early detection is crucial.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.